IDev Technologies (IDEV) is an organization focused on innovation, inspiration, and next generation medical device products designed for endovascular interventional use.
While the current IDEV patent portfolio contains over thirty technologies exclusively licensed from the M.D. Anderson Cancer Center, the current focus of the company is on the successful commercialization of a novel interwoven nitinol self-expanding stent for use in hepatic biliary disease. The unique interwoven nitinol design of the SUPERA™ stent will create a new class of self-expanding nitinol stents that are superior to traditional laser cut tube stents. The interwoven nitinol design essentially provides both unsurpassed strength and flexibility which ultimately leads to greater durability compared to all existing nitinol stent products.